As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the immuno ...

CytomX's Phase I trial of ADC CX-2051 in colorectal cancer will continue based on a decision made by a safety committee ...

Regeneron’s second quarter was marked by robust growth in key products, which the company attributed to the strong commercial ...

Dr. Reid brings 30 years of experience in building biotech companies based on innovative scientific platforms and shaping ...

Strand Therapeutics announced on Thursday that it landed a $153 million Series B funding led by Kinnevik. The company’s ...

TARRYTOWN, N.Y. (AP) — TARRYTOWN, N.Y. (AP) — Regeneron Pharmaceuticals Inc. (REGN) on Friday reported second-quarter earnings of $1.39 billion.

TARRYTOWN, N.Y. (AP) — TARRYTOWN, N.Y. (AP) — Regeneron Pharmaceuticals Inc. (REGN) on Friday reported second-quarter earnings of $1.39 billion.

Suspended CEO Arthur T. Demoulas said the Board of Directors is trying to silence employees who want the company's management restored.

Bluesky CEO Jay Graber said developing critical-thinking skills is "very necessary" in today's job market. She said human oversight is needed, and you shouldn't "fully outsource your thinking" to AI.

Issa Asad, CEO of Florida telecom firm Q Link, was sentenced to five years in prison after he and the company stole money from a federal program that provides discounted phone services.

Software company C3.ai Inc. is looking for a new chief executive officer after Tom Siebel said he intends to step aside due to health concerns.